Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in J Thorac Cardiovasc Surg Retrieve available abstracts of 102 articles: HTML format

Single Articles

April 2024
1. BLEIWEIS MS, Philip J, Peek GJ, Jacobs JP, et al
   Commentary: Challenges associated with long-term implantable ventricular assist device support in children.
   J Thorac Cardiovasc Surg. 2024;167:1429-1430.
   PubMed    
   
   
   
2. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
   A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
   J Thorac Cardiovasc Surg. 2024;167:1322-1330.
   PubMed     Abstract available
   
   
   March 2024
3. AZIZGOLSHANI N, Takeda K
   Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
   J Thorac Cardiovasc Surg. 2024;167:1060-1061.
   PubMed    
   
   
   February 2024
4. SINGH SK, Hassanein M, Ning Y, Wang C, et al
   Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
   J Thorac Cardiovasc Surg. 2024;167:535-543.
   PubMed     Abstract available
   
   
   
5. VINOGRADSKY A, Ning Y, Kurlansky P, Kirschner M, et al
   Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy.
   J Thorac Cardiovasc Surg. 2024;167:731-743.
   PubMed     Abstract available
   
   
   
6. DIMAGLI A, Worku B, Gaudino M
   Commentary: Minimally invasive left ventricular assist device implantation: Did we forget the valve?
   J Thorac Cardiovasc Surg. 2024;167:744-745.
   PubMed    
   
   
   January 2024
7. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
   Total artificial heart implantation as a bridge to transplantation in the United States.
   J Thorac Cardiovasc Surg. 2024;167:205-214.
   PubMed     Abstract available
   
   
   December 2023
8. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
   Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
   J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
   PubMed     Abstract available
   
   
   
9. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
   Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
   J Thorac Cardiovasc Surg. 2023;166:1756-1763.
   PubMed     Abstract available
   
   
   
10. JOHN R, Kanwar MK, Cleveland JC Jr, Uriel N, et al
    Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial
    J Thorac Cardiovasc Surg. 2023;166:1684-1694.
    PubMed     Abstract available
    
    
    October 2023
11. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available
    
    
    
12. DECAMPLI WM
    Commentary: Is machine learning needed to understand that heart failure is a risk in adult congenital cardiac surgery?
    J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00977.
    PubMed    
    
    
    
13. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available
    
    
    
14. MOAZAMI N, Smith D
    Commentary: Direct cardiac compression device for biventricular support: If we put lipstick on a pig, is it still a pig?
    J Thorac Cardiovasc Surg. 2023;166:1130-1131.
    PubMed    
    
    
    September 2023
15. GRIFFETH EM, Stephens EH, Dearani JA, Shreve JT, et al
    Impact of Heart Failure on Reoperation in Adult Congenital Heart Disease: An Innovative Machine Learning Model.
    J Thorac Cardiovasc Surg. 2023 Sep 28:S0022-5223(23)00871.
    PubMed     Abstract available
    
    
    August 2023
16. ZHOU S, Yang G, Zhang M, Pienta M, et al
    Mortality following durable left ventricular assist device implantation by timing and type of first infection.
    J Thorac Cardiovasc Surg. 2023;166:570-579.
    PubMed     Abstract available
    
    
    July 2023
17. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    
    
    
    June 2023
18. KULSHRESTHA K, Greenberg JW, Kennedy JT 3rd, Hogue S, et al
    National Experience with Pediatric Surgical Aortic Valve Repair - A Pediatric Health Information System Analysis.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00538.
    PubMed     Abstract available
    
    
    
19. LIU R, Li S, Yan J, Yan F, et al
    Fate of Transposition of the Great Arteries with Pulmonary Stenosis After Double-Root Translocation, Rastelli, and Reparation a l'Etage Ventriculaire.
    J Thorac Cardiovasc Surg. 2023 Jun 7:S0022-5223(23)00455.
    PubMed     Abstract available
    
    
    
20. PIENTA MJ, Noly PE, Janda AM, Tang PC, et al
    Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device.
    J Thorac Cardiovasc Surg. 2023;165:2126-2131.
    PubMed    
    
    
    
21. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available
    
    
    
22. KILCOYNE MF, Blanding WM, Kilic A
    Commentary: Left ventricular assist device implantation and failure to rescue: New insights and familiar challenges.
    J Thorac Cardiovasc Surg. 2023;165:2124-2125.
    PubMed    
    
    
    April 2023
23. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed     Abstract available
    
    
    March 2023
24. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    
    
    
    
25. YOUNG BAC, Tang PC
    Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?
    J Thorac Cardiovasc Surg. 2023;165:1125-1126.
    PubMed    
    
    
    
26. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available
    
    
    
27. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    
    
    
    December 2022
28. BLANDING W, Kilic A
    Demise of HVAD: The only constant is change.
    J Thorac Cardiovasc Surg. 2022;164:1945-1947.
    PubMed    
    
    
    
29. BOSSERS GPL, Gunthel M, van der Feen DE, Hagdorn QAJ, et al
    Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load.
    J Thorac Cardiovasc Surg. 2022;164:e493-e510.
    PubMed     Abstract available
    
    
    
30. BALACHANDRAN I, Frazier OH, Rogers JG
    Doing the wrong thing for the right reasons: The demise of the HVAD.
    J Thorac Cardiovasc Surg. 2022;164:1937-1941.
    PubMed    
    
    
    
31. KIRKLIN JK
    Commentary: Collateral impact of the HVAD decision and the path forward.
    J Thorac Cardiovasc Surg. 2022;164:1942-1943.
    PubMed    
    
    
    
32. BROWN JA, Aranda-Michel E, Kilic A, Serna-Gallegos D, et al
    The impact of pulmonary artery catheter use in cardiac surgery.
    J Thorac Cardiovasc Surg. 2022;164:1965-1973.
    PubMed     Abstract available
    
    
    
33. FARSKY PS, White J, Al-Khalidi HR, Sueta CA, et al
    Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
    J Thorac Cardiovasc Surg. 2022;164:1890-1899.
    PubMed     Abstract available
    
    
    
34. HRYTSYNA Y, Kneissler S, Kaufmann F, Muller M, et al
    Experience with a standardized protocol to predict successful explantation of left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1922-1930.
    PubMed     Abstract available
    
    
    
35. JAWAD K, Sipahi F, Koziarz A, Huhn S, et al
    Less-invasive ventricular assist device implantation: A multicenter study.
    J Thorac Cardiovasc Surg. 2022;164:1910-1918.
    PubMed     Abstract available
    
    
    
36. BROWN JA, Sultan I
    Commentary: Sometimes less is more: The minimally invasive argument for ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1920-1921.
    PubMed    
    
    
    November 2022
37. CHO J, Fuentes-Baldemar AA, Tunuguntla HP, Spinner JA, et al
    Outcomes of temporary ventricular assist device: A pediatric institutional experience over 25 years.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01164.
    PubMed     Abstract available
    
    
    
38. SILVESTRY SC
    Commentary: Left ventricular assist device complications after heart transplantation: Then and now.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01173.
    PubMed    
    
    
    
39. BLANDING WM, Kilic A
    Commentary: Durable left ventricular assist device infections: A call to arms.
    J Thorac Cardiovasc Surg. 2022;164:1570-1571.
    PubMed    
    
    
    
40. LIKOSKY DS, Yang G, Zhang M, Malani PN, et al
    Interhospital variability in health care-associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries.
    J Thorac Cardiovasc Surg. 2022;164:1561-1568.
    PubMed     Abstract available
    
    
    October 2022
41. HAYWARD C, Adachi I, Baudart S, Davis E, et al
    Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.
    J Thorac Cardiovasc Surg. 2022;164:1120-1137.
    PubMed     Abstract available
    
    
    
42. GOUTALLIER CS, Buratto E, Schulz A, Hu T, et al
    Repair of complete atrioventricular septal defect between 2 and 3.5 kilograms: Defining the limits of safe repair.
    J Thorac Cardiovasc Surg. 2022;164:1167-1175.
    PubMed     Abstract available
    
    
    
43. TOMINAGA Y, Taira M, Watanabe T, Hasegawa M, et al
    Clinical significance of diastolic dysfunction on outcomes of pulmonary valve replacement for pulmonary insufficiency.
    J Thorac Cardiovasc Surg. 2022;164:1156-1164.
    PubMed     Abstract available
    
    
    
44. TOSO A, Castelvecchio S, Menicanti L, Volpe M, et al
    Prognostic value of natriuretic peptides and restrictive filling pattern before surgical ventricular restoration.
    J Thorac Cardiovasc Surg. 2022;164:1092-1101.
    PubMed     Abstract available
    
    
    September 2022
45. SHAH AS
    Commentary: When a ventricular assist device is just not enough.
    J Thorac Cardiovasc Surg. 2022;164:978.
    PubMed    
    
    
    August 2022
46. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available
    
    
    
47. BEDZRA EKS, Adachi I, Peng DM, Amdani S, et al
    Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs Databases.
    J Thorac Cardiovasc Surg. 2022;164:353-364.
    PubMed     Abstract available
    
    
    June 2022
48. SALERNO CT, Hayward C, Hall S, Goldstein D, et al
    HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
    J Thorac Cardiovasc Surg. 2022;163:2120-2127.
    PubMed     Abstract available
    
    
    
49. SHAFII A, Liao K, Ghanta RK
    Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall.
    J Thorac Cardiovasc Surg. 2022;163:2129-2130.
    PubMed    
    
    
    
50. DEO SV, Sundaram V, Wilson B, Sahadevan J, et al
    Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database.
    J Thorac Cardiovasc Surg. 2022;163:2096-2103.
    PubMed     Abstract available
    
    
    April 2022
51. GAUDINO M, Castelvecchio S, Rahouma M, Robinson NB, et al
    Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial.
    J Thorac Cardiovasc Surg. 2022 Apr 26. pii: S0022-5223(22)00493.
    PubMed     Abstract available
    
    
    
52. MAH KE, Morales DLS
    Commentary: The Vulcan mind MELD-XI.
    J Thorac Cardiovasc Surg. 2022;163:1477-1478.
    PubMed    
    
    
    February 2022
53. KIM HR, Kim WK, Kim JK, Kim HJ, et al
    Prognostic impact of the E/e' ratio in patients with chronic severe aortic regurgitation undergoing aortic valve replacement.
    J Thorac Cardiovasc Surg. 2022 Feb 2. pii: S0022-5223(22)00114.
    PubMed     Abstract available
    
    
    
54. ZHU Y, Shudo Y, Lingala B, Baiocchi M, et al
    Outcomes after heart retransplantation: A 50-year single-center experience.
    J Thorac Cardiovasc Surg. 2022;163:712-720.
    PubMed     Abstract available
    
    
    
55. BIANCO V, Kilic A, Yousef S, Serna-Gallegos D, et al
    The long-term impact of postoperative atrial fibrillation after cardiac surgery.
    J Thorac Cardiovasc Surg. 2022 Feb 1. pii: S0022-5223(22)00103.
    PubMed     Abstract available
    
    
    January 2022
56. ALSOUFI B
    Commentary: Heart transplantation listing for children with significant renal insufficiency: The need for a paradigm shift.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00006.
    PubMed    
    
    
    
57. NIKOLOVA A, Youn JC, Kobashigawa JA
    Commentary: The anticlimax of the left ventricular assist devices-associated antibodies.
    J Thorac Cardiovasc Surg. 2022;163:136-137.
    PubMed    
    
    
    
58. BAKIR NH, Finnan MJ, MacGregor RM, Schilling JD, et al
    Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;163:124-134.
    PubMed     Abstract available
    
    
    November 2021
59. ELGHARABLY H, Ibrahim A, Rosinski B, Thuita L, et al
    Right heart failure and patient selection for isolated tricuspid valve surgery.
    J Thorac Cardiovasc Surg. 2021 Nov 25. pii: S0022-5223(21)01657.
    PubMed     Abstract available
    
    
    
60. MENNANDER AA
    Commentary: Preventive treatment of right-sided heart failure before adulthood?
    J Thorac Cardiovasc Surg. 2021 Nov 4. pii: S0022-5223(21)01533.
    PubMed    
    
    
    
61. LI S, Zimpfer D, Mahr C
    Commentary: Transcending acceptable, moving toward optimal: Standardizing surgical configurations of ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:1566-1567.
    PubMed    
    
    
    
62. KASINPILA P, Kong S, Fong R, Shad R, et al
    Use of patient-specific computational models for optimization of aortic insufficiency after implantation of left ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:1556-1563.
    PubMed     Abstract available
    
    
    October 2021
63. YANG B, Caceres J, Farhat L, Le T, et al
    Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes.
    J Thorac Cardiovasc Surg. 2021;162:1049-1059.
    PubMed     Abstract available
    
    
    September 2021
64. BRAHMBHATT DH, Rao V
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.
    PubMed    
    
    
    
65. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available
    
    
    
66. RAJAGOPAL K, Cheema FH, Omer S
    Commentary: Heart failure and the problem of causality.
    J Thorac Cardiovasc Surg. 2021 Sep 8. pii: S0022-5223(21)01300.
    PubMed    
    
    
    August 2021
67. PERRY T, Morales DLS
    Commentary: Promise with pulsatility? Early bridging of high-risk patients with single-ventricle physiology with a ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:415-416.
    PubMed    
    
    
    
68. SILVESTRY SC
    Commentary: Better pumps, better patients, better physicians? Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:612-613.
    PubMed    
    
    
    
69. MOON J, Adachi I
    Commentary: Ventricular assist device support in an early infancy with single ventricle: Transformation from salvage to elective.
    J Thorac Cardiovasc Surg. 2021;162:416-417.
    PubMed    
    
    
    
70. LEE MM, Honjo O
    Commentary: How to VAD to avoid BAD in high-risk single ventricle.
    J Thorac Cardiovasc Surg. 2021;162:414-415.
    PubMed    
    
    
    
71. MILANO CA
    Commentary: Managing the native heart in patients supported with durable left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2021;162:613-614.
    PubMed    
    
    
    
72. KILIC A
    Commentary: Left ventricular assist device therapy: The time is now.
    J Thorac Cardiovasc Surg. 2021;162:614-615.
    PubMed    
    
    
    
73. DESHPANDE S, Alsoufi B
    Meeting needs-pushing boundaries: Mechanical circulatory support in children; year in review.
    J Thorac Cardiovasc Surg. 2021;162:400-404.
    PubMed    
    
    
    
74. SHAFFER A, Cogswell R, John R
    Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:605-611.
    PubMed    
    
    
    July 2021
75. ALSOUFI B
    Commentary: Mitochondrial transplantation for myocardial failure, marvel remedy or wishful thinking?
    J Thorac Cardiovasc Surg. 2021;162:e125-e126.
    PubMed    
    
    
    
76. ATLURI P, Balsam LB
    Invited Expert Opinion papers on mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021;162:140-142.
    PubMed    
    
    
    June 2021
77. LEE SH, Choi KH, Song YB, Jeong DS, et al
    Comprehensive assessment of heart failure in patients with preserved ejection fraction undergoing coronary bypass grafting.
    J Thorac Cardiovasc Surg. 2021 Jun 19. pii: S0022-5223(21)00980.
    PubMed     Abstract available
    
    
    
78. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.
    PubMed    
    
    
    
79. BENAZZO A, Bajorek L, Morscher A, Schrutka L, et al
    Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 1. pii: S0022-5223(21)00879.
    PubMed     Abstract available
    
    
    May 2021
80. DESHPANDE S, Sparks JD, Alsoufi B
    Pediatric heart transplantation: Year in review 2020.
    J Thorac Cardiovasc Surg. 2021 May 3. pii: S0022-5223(21)00758.
    PubMed    
    
    
    April 2021
81. BAKAEEN FG, Gaudino M, Whitman G, Doenst T, et al
    2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.
    J Thorac Cardiovasc Surg. 2021 Apr 30. pii: S0022-5223(21)00736.
    PubMed    
    
    
    
82. TIMEK TA
    Commentary: The pneumatic para-trouper.
    J Thorac Cardiovasc Surg. 2021;161:1467-1468.
    PubMed    
    
    
    
83. VILLA CR, Morales DLS
    Commentary: Rejuvenation of a trusted tool.
    J Thorac Cardiovasc Surg. 2021;161:1466-1467.
    PubMed    
    
    
    
84. KIRKLIN JK
    Commentary: Adult support with a pulsatile VAD: Reawakening of a bygone era?
    J Thorac Cardiovasc Surg. 2021;161:1465-1466.
    PubMed    
    
    
    March 2021
85. FERRARIS VA
    Commentary: Benefits of SGLT2 inhibition in heart failure: A bellwether for importance of other metabolic pathways.
    J Thorac Cardiovasc Surg. 2021 Mar 27. pii: S0022-5223(21)00554.
    PubMed    
    
    
    
86. AMBROSIO G, Mattioli R, Carluccio E
    Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism.
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00416.
    PubMed    
    
    
    
87. LAZAR HL
    Commentary: SGLT2 inhibitors reduce mortality and heart failure in patients with type 2 diabetes mellitus-is metabolic reprogramming the mechanism for these favorable outcomes?
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00415.
    PubMed    
    
    
    
88. MANN PA, Lehrke M
    Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition?
    J Thorac Cardiovasc Surg. 2021 Mar 3. pii: S0022-5223(21)00410.
    PubMed    
    
    
    February 2021
89. CASTELVECCHIO S, Frigelli M, Sturla F, Milani V, et al
    Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: A 3-dimensional ultrasound analysis.
    J Thorac Cardiovasc Surg. 2021 Feb 26. pii: S0022-5223(21)00381.
    PubMed     Abstract available
    
    
    
90. SOLTESZ EG
    Commentary: To fix or not to fix? That is the question for mitral and aortic valve surgery during left ventricular assist devices implantation.
    J Thorac Cardiovasc Surg. 2021 Feb 18. pii: S0022-5223(21)00344.
    PubMed    
    
    
    
91. MELEHY A, Sanchez JE, Nemeth SK, Kurlansky PA, et al
    National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00213.
    PubMed     Abstract available
    
    
    January 2021
92. HAWKINS RB, Mehaffey JH
    Commentary: Is heart failure with moderately reduced ejection fraction a useful classification for cardiac surgery?
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00179.
    PubMed    
    
    
    
93. DEO SV, Sundaram V, Sahadevan J, Selvaganesan P, et al
    Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00132.
    PubMed     Abstract available
    
    
    December 2020
94. HIRJI SA, Cote CL, Javadikasgari H, Malarczyk A, et al
    Atrial functional versus ventricular functional mitral regurgitation: Prognostic implications.
    J Thorac Cardiovasc Surg. 2020 Dec 31. pii: S0022-5223(20)33453.
    PubMed     Abstract available
    
    
    
95. TANAKA Y, Nakajima T, Fischer I, Wan F, et al
    The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.
    J Thorac Cardiovasc Surg. 2020;160:1490-1500.
    PubMed     Abstract available
    
    
    November 2020
96. RIGGS KW, Morales DLS, Zafar F
    Commentary: Is two ever better than one in pediatric ventricular assist device support? The controversy continues.
    J Thorac Cardiovasc Surg. 2020;160:1309-1310.
    PubMed    
    
    
    September 2020
97. SILVESTRY SC
    Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.
    J Thorac Cardiovasc Surg. 2020 Sep 9. pii: S0022-5223(20)32581.
    PubMed    
    
    
    
98. SOLTESZ EG
    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.
    PubMed    
    
    
    
99. ONOHARA D, Corporan DM, Kono T, Kumar S, et al
    Ventricular reshaping with a beating heart implant improves pump function in experimental heart failure.
    J Thorac Cardiovasc Surg. 2020 Sep 3. pii: S0022-5223(20)32535.
    PubMed     Abstract available
    
    
    
100. BANSAL A, Goldstein D, Schettle S, Pepitone S, et al
     Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
     J Thorac Cardiovasc Surg. 2020 Sep 2. pii: S0022-5223(20)32490.
     PubMed    
     
     
     July 2020
101. KIRKLIN JK
     Commentary: Absence of ventricular assist device-related risk for rejection after heart transplantation: Good news given the "new normal".
     J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32053.
     PubMed    
     
     
     February 2020
102. SILVER SA, Long J, Zheng Y, Goldstone AB, et al
     Outcomes after left ventricular assist device implantation in patients with acute kidney injury.
     J Thorac Cardiovasc Surg. 2020;159:477-486.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.